跳至主要内容
临床试验/IRCT20190210042676N8
IRCT20190210042676N8尚未招募2 期

Efficacy and safety assessment of a formulated topical cream containing Ginger for treatment of mild to moderate melasma

Sina Trading Company0 个研究点目标入组 28 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Cases of mild to moderate melasma (MGSC=1& 2)
  • General health
  • Signing the consent form for participation in the study

排除标准

  • Documented allergies to components of cream
  • Use of topical lightening products like AHA ,BHA and retinoid component within 21 days prior to the study
  • Active skin disease at test area: rosacea, atrophy, acne and eczema
  • Pregnancy or lactating
  • Use of systemic corticosteroid and isotretinoin within 28 days prior to the study
  • History of laser treatment or dermabrasion or deep facialpeels within the past 3 months

研究者

发起方
Sina Trading Company

相似试验